Surgery Partners, Inc. (SGRY) Tops Q3 EPS by 5c; Offers FY23 Revenue Guidance
Surgery Partners, Inc. (NASDAQ: SGRY) reported Q3 EPS of $0.19, $0.05 better than the analyst estimate of $0.14. Revenue for the quarter came in at $674.1 million versus the consensus estimate of $671.99 million.
GUIDANCE:
Surgery Partners, Inc. sees FY2023 revenue of $2.75 billion, versus the consensus of $2.76 billion.
For earnings history and earnings-related data on Surgery Partners, Inc. (SGRY) click here.
